Dapagliflozin

Dapagliflozin is an oral medication that belongs to a class of drugs known as sodium-glucose cotransporter-2 (SGLT2) inhibitors. It is primarily used to manage type 2 diabetes in adults. By inhibiting the SGLT2 transporter in the kidneys, dapagliflozin helps the body eliminate excess glucose through urine, thereby reducing blood sugar levels.
In addition to its primary function in blood sugar management, dapagliflozin has been shown to provide additional benefits to patients with type 2 diabetes. These benefits include a reduction in body weight and blood pressure, as well as a lower risk of developing heart-related complications. However, note that dapagliflozin is not intended for use in managing type 1 diabetes or diabetic ketoacidosis.
Before starting dapagliflozin, healthcare professionals should carefully assess the patient’s medical history, including kidney function and heart conditions. The medication is usually prescribed as a single dose, taken once daily, preferably in the morning. Patients should follow their healthcare provider’s instructions and regularly monitor their blood sugar levels while on this medication.